Loading…
Gynecologic Cancers Statistics in the I.R. Iran in 2020
Background: Gynecologic cancers (GCs) are among the leading causes of morbidity and mortality in females worldwide. Estimating the cancer burden is invaluable to set up priorities for research funding allocations, cancer control policies, and prevention strategies. The International Agency for Resea...
Saved in:
Published in: | Basic and clinical cancer research 2022-02, Vol.13 (2) |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background: Gynecologic cancers (GCs) are among the leading causes of morbidity and mortality in females worldwide. Estimating the cancer burden is invaluable to set up priorities for research funding allocations, cancer control policies, and prevention strategies. The International Agency for Research on Cancer (IARC) has recently released the latest estimates on the prevalence, incidence, and mortality for 36 types of cancer and all cancer sites combined in 185 countries in 2020. Methods: We obtained data on the incidence, mortality, and prevalence of GCs in the Iranian female population from the GLOBOCAN 2020 database presented by the IARC, compared the burden with the previous reports presented in 2012 and 2018, and provided the estimates for 2040. In addition, we compared the burden to that of the WHO Eastern Mediterranean Region (EMRO) and the world. Results: There has been a slight increase in the incidence of GCs in recent years after stable rates for a couple of decades. The growing availability of incidence rates from population-based cancer registries (PBCRs) and mortality rates from vital statistics offices in Iran may account for the increasing trend. Conclusions: Cancer awareness campaigns and high-quality prevention programs may result in better GC prevention among women. |
---|---|
ISSN: | 2228-6527 2228-5466 |